• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home Uncategorized

Mindfulness-based therapy associated with improvement in quality of life for PTSD patients

byJohn PrendergassandPriyanka Vedak
August 5, 2015
in Uncategorized
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In this study, mindfulness-based stress reduction (MBSR) therapy resulted in a greater reduction in self-reported post-traumatic stress disorder (PTSD) symptoms and improved quality of life compared to present-centered therapy (PCT).

2. There was no significant difference in PTSD diagnosis status after treatment or at 2-month follow-up between the two groups.

Evidence Rating Level: 1(Excellent)

Study Rundown: Post-traumatic stress disorder (PTSD) is triggered by life-threating events, with subsequent symptoms including nightmares, intrusive memories, emotional distress, feelings of numbness, and hopelessness, among others. Individuals with PTSD are at a greater risk of suicide, depression, and substance use disorders. Current treatment options for PTSD include cognitive therapy, exposure therapy, antidepressants, and anti-anxiety medications. Two additional options for treatment are mindfulness-based stress reduction (MBSR) and present-centered therapy (PCT). While the former option teaches meditation practices to the individual, the latter emphasizes the individual’s existing strengths in order to cope with stressors. The authors of this study compared these two methods as treatment options for PTSD in a randomized controlled trial.

The authors of this study found that MBSR resulted in a greater reduction in self-reported PTSD symptoms at 2-month follow-up as well as an improved quality of life when compared to PCT. There was no significant difference however in the rates of self-reported depressive symptoms or PTSD diagnosis status observed between the two groups. While this study was strengthened by its randomized controlled trial design, it was limited by the short follow-up period of 2 months, restricting our understanding of either treatment’s long-term effects. Due to inherent differences in the amount of contact required for either type of treatment (2.5 hour group sessions for MBSR and 1.5 hour group sessions for PCT), individuals in the active arm of this study received more clinician interaction than those in the control arm, potentially confounding results. Nevertheless, treatments such as MBSR may expand the therapeutic options available for PTSD. Future studies in this area should focus on further validation of such alternative PTSD treatments, particularly through long-term follow-up studies.

Click to read the study, published today in JAMA

Click to read the accompanying editorial in JAMA

RELATED REPORTS

Cognitive behavioral therapy efficacious for treatment of comorbid posttraumatic headache and posttraumatic stress disorder symptoms among US veterans

Sickle cell trait associated with preexisting kidney comorbidities and increased COVID-19 mortality

Adding atezolizumab to standard of care treatment for human epidermal growth factor receptor 2 (HER2) positive early breast cancer does not improve pathologic response outcomes

Relevant Reading: Meditation programs for psychological stress and well-being

In-Depth [randomized controlled trial]: This study evaluated 116 veterans with PTSD from the Minneapolis Veterans Affairs Medical Center between March 2012 and December 2013. Inclusion criteria were that veterans met a diagnosis of full or subthreshold PTSD per DSM-IV criteria, participated in no other PTSD psychotherapy during the study period, and received either no medications or were on a stable medication regimen. MBSR resulted in a greater reduction in self-reported PTSD symptoms according to the PTSD checklist at post-treatment and at 2-month follow-up from scores of 63.6 to 55.7 and then 54.4 vs. PCT, from 58.8 to 55.8 and then 56.0 (p = 0.002 and p 0<0.001, respectively). MBSR participants reported greater improvement in quality of life from baseline to 2-month follow-up than did those in PCT (mean score improvement MBSR from 75.6 to 80.2 vs. PCT from 76.4 to 75.8; mean difference in improvement 5.22, 95%CI 1.73-8.71). Differences between the two groups for change in PTSD diagnosis status after treatment and at 2 months follow-up between the two groups were not significant (42.3% and 53.3% loss of diagnosis of PTSD with MBSR, respectively; and 43.9% and 47.3% loss of diagnosis of PTSD with PCT, respectively).

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Previous Post

Vitamin D supplementation amongst post-menopausal women did not improve functional outcomes

Next Post

Even low levels of physical activity reduce mortality in elderly

RelatedReports

Galcanezumab reduces the frequency of episodic cluster headaches
Chronic Disease

Cognitive behavioral therapy efficacious for treatment of comorbid posttraumatic headache and posttraumatic stress disorder symptoms among US veterans

July 4, 2022
Stem cell transplant may be effective in sickle cell disease
Chronic Disease

Sickle cell trait associated with preexisting kidney comorbidities and increased COVID-19 mortality

July 4, 2022
New genetic link in pulmonary arterial hypertension holds therapeutic promise
Oncology

Adding atezolizumab to standard of care treatment for human epidermal growth factor receptor 2 (HER2) positive early breast cancer does not improve pathologic response outcomes

July 4, 2022
Oncology

FOLFOX combined with nivolumab and trastuzumab in ERBB2-positive esophagogastric adenocarcinoma is an emerging therapy option

July 4, 2022
Next Post
Physical therapy for hip osteoarthritis may not lead to significant benefits

Even low levels of physical activity reduce mortality in elderly

Repeat Transrectal Prostate Biopsies May Increase Infection Risk

Combination of early docetaxel therapy linked to increased survival in metastatic prostate cancer patients

2 Minute Medicine Rewind January 13-19, 2014

Topical intracoital tenofovir gel linked to decreased incidence of herpes simplex virus type 2

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Cognitive behavioral therapy efficacious for treatment of comorbid posttraumatic headache and posttraumatic stress disorder symptoms among US veterans
  • Sickle cell trait associated with preexisting kidney comorbidities and increased COVID-19 mortality
  • Adding atezolizumab to standard of care treatment for human epidermal growth factor receptor 2 (HER2) positive early breast cancer does not improve pathologic response outcomes
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.